Form 4: J&J Executive Exercises Options, Sells Shares
Insider Transaction Report
Johnson & Johnson's Executive VP, General Counsel, Elizabeth Forminard, exercised stock options and subsequently sold a portion of the acquired shares.
Summary
- Elizabeth Forminard, Executive VP, General Counsel of Johnson & Johnson (JNJ), exercised 11,521 employee stock options on August 29, 2025.
- The exercise price for these options was $115.67 per share.
- Upon exercise, 11,521 shares of Johnson & Johnson common stock were acquired.
- Following the acquisition, 9,570 shares of common stock were disposed of at a price of $177.20 per share.
- This disposition was made under transaction code 'F', indicating it was likely for tax withholding purposes or to cover the exercise cost.
- After these transactions, direct beneficial ownership of common stock is 12,853 shares, and all 11,521 employee stock options were disposed of (exercised), leaving 0 options beneficially owned.
Sentiment
Score: 6
Explanation: The exercise of options indicates the executive sees value in the stock, but the subsequent sale, even if for tax purposes, slightly offsets the positive signal of the exercise. It's a routine compensation event.
Positives
- Executive Forminard exercised options, indicating a belief in the company's stock value above the exercise price of $115.67.
- The sale price of $177.20 per share is significantly higher than the exercise price, demonstrating a substantial gain for the executive from the equity compensation.
Negatives
- The disposition of 9,570 shares, even if for tax purposes, reduces the executive's direct equity stake in the company.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance.
Industry Context
This Form 4 filing details a routine insider transaction involving the exercise of stock options and subsequent sale of shares, which is a common occurrence for executives receiving equity compensation. It does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders: The exercise and partial sale by an executive is a normal part of compensation. The exercise itself implies the executive believes the stock is worth more than the exercise price, which can be viewed positively. The reduction in direct ownership is a neutral to slightly negative signal.
Key Dates
| Date | Description |
|---|---|
| 02/13/2020 | Grant date of employee stock options, which vested and became exercisable on their third anniversary. |
| 08/29/2025 | Date of employee stock option exercise and subsequent common stock disposition. |
| 09/03/2025 | Signature date of the reporting person's attorney-in-fact. |
| 02/13/2027 | Expiration date of the employee stock options. |
Recommendation
holdThis Form 4 filing details a routine insider transaction where an executive exercised stock options and sold a portion of the acquired shares, likely for tax purposes. While the exercise indicates confidence in the stock's value above the strike price, the subsequent sale is a common practice for managing equity compensation. The transaction does not provide new fundamental information about Johnson & Johnson's business operations, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this event is neutral to the company's long-term investment thesis.
Keywords
Johnson & Johnson, JNJ, Elizabeth Forminard, Insider Transaction, Stock Options, Share Sale, Executive Compensation, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.